Abstract:Mammalian spermatogenesis is a highly regulated multistage process of sperm generation. It is hard to uncover the real function of a testis specific gene in vitro since the in vitro model is not yet mature. With the development of the CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated 9) system, we can now rapidly generate knockout mouse models of testis specific genes to study the process of spermatogenesis in vivo. SYCP3-like X-linked 2 (SLX2) is a germ cell specific component, which contains a Cor1 domain and belongs to the XLR (X-linked, lymphocyte regulated) family. Previous studies suggested that SLX2 might play an important role in mouse spermatogenesis based on its subcellular localization and interacting proteins. However, the function of SLX2 in vivo is still elusive. Here, to investigate the functions of SLX2 in spermatogenesis, we disrupted the Slx2 gene by using the CRISPR/Cas9 system. Since Slx2 is a testis specific X-linked gene, we obtained knockout male mice in the first generation and accelerated the study process. Compared with wild-type mice, Slx2 knockout mice have normal testis and epididymis. Histological observation of testes sections showed that Slx2 knockout affected none of the three main stages of spermatogenesis: mitosis, meiosis and spermiogenesis. In addition, we further confirmed that disruption of Slx2 did not affect the number of spermatogonial stem cells, meiosis progression or XY body formation by immunofluorescence analysis. As spermatogenesis was normal in Slx2 knockout mice, these mice were fertile. Taken together, we showed that Slx2 itself is not an essential gene for mouse spermatogenesis and CRISPR/Cas9 technique could speed up the functional study of testis specific X-linked gene in vivo.

Adeno-associated-virus-mediated delivery of CRISPR-CasRx induces efficient RNA knockdown in the mouse testis

CRISPR/Cas9 Promotes Functional Study of Testis Specific X-Linked Gene in Vivo

Spermatogenic Cell-Specific Gene Mutation in Mice Via CRISPR-Cas9.

A CRISPR/RfxCas13d-mediated strategy for efficient RNA knockdown in mouse embryonic development

Protocol for in vivo CRISPR screening targeting murine testicular cells

RNA-guided transcriptional silencing in vivo with S. aureus CRISPR-Cas9 repressors

<i>In vivo PCSK9</i> gene editing using an all-in-one self-cleavage AAV-CRISPR system

Investigating the potential of X chromosome shredding for mouse genetic biocontrol

Precise transcript targeting by CRISPR-Csm complexes

Efficient Gene Editing in Adult Mouse Livers Via Adenoviral Delivery of CRISPR/Cas9.

Targeted Delivery of CRISPR/Cas9 to Prostate Cancer by Modified Grna Using a Flexible Aptamer-Cationic Liposome

CASAAV: A CRISPR‐Based Platform for Rapid Dissection of Gene Function in Vivo

Delivery of CRISPR/Cas9 system by AAV as vectors for gene therapy

Individual disruption of 12 testis-enriched genes via the CRISPR/Cas9 system does not affect the fertility of male mice

CRISPR/cas9, a Novel Genomic Tool to Knock Down Microrna in Vitro and in Vivo.

Comparing robotic and manual injection methods in zebrafish embryos for high-throughput RNA silencing using CRISPR-RfxCas13d

Generation and validation of versatile inducible CRISPRi embryonic stem cell and mouse model

Ubiquitous and Tissue-specific RNA Targeting in Drosophila Melanogaster Using CRISPR/CasRx

A platform to deliver single and bi-specific Cas9/guide RNA to perturb genes in vitro and in vivo

In Situ Gene Therapy Via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation.

Gene-deficient mouse model established by CRISPR/Cas9 system reveals 15 reproductive organ-enriched genes dispensable for male fertility